Pro-apoptotic effect of an anti-CD37 scFv-Fc fusion protein, in combination with the anti-CD20 antibody, ofatumumab, on tumour cells from B-cell malignancies.

MLA

Smolewski, Piotr, et al. “Pro-Apoptotic Effect of an Anti-CD37 ScFv-Fc Fusion Protein, in Combination with the Anti-CD20 Antibody, Ofatumumab, on Tumour Cells from B-Cell Malignancies.” European Journal of Cancer, vol. 50, no. 15, Oct. 2014, pp. 2677–84. EBSCOhost, https://doi.org/10.1016/j.ejca.2014.07.021.

APA

Smolewski, P., Robak, P., Cebula-Obrzut, B., Misiewicz, M., Mędra, A., Majchrzak, A., Witkowska, M., Stromatt, S., & Robak, T. (2014). Pro-apoptotic effect of an anti-CD37 scFv-Fc fusion protein, in combination with the anti-CD20 antibody, ofatumumab, on tumour cells from B-cell malignancies. European Journal of Cancer, 50(15), 2677–2684. https://doi.org/10.1016/j.ejca.2014.07.021

Chicago

Smolewski, Piotr, Pawel Robak, Barbara Cebula-Obrzut, Małgorzata Misiewicz, Aleksandra Mędra, Agata Majchrzak, Magdalena Witkowska, Scott Stromatt, and Tadeusz Robak. 2014. “Pro-Apoptotic Effect of an Anti-CD37 ScFv-Fc Fusion Protein, in Combination with the Anti-CD20 Antibody, Ofatumumab, on Tumour Cells from B-Cell Malignancies.” European Journal of Cancer 50 (15): 2677–84. doi:10.1016/j.ejca.2014.07.021.